Skip to Content (Press Enter)

Agent News

More Under-65 products move to new commission system

Additional Arkansas Blue Cross and Blue Shield individual product commissions will be paid to agents and agencies using the new commission system – ICM – beginning in January 2018.

ICM is currently the commission system for:

  • Medi-Pak Advantage
  • Medi-Pak Part D
  • Individual metallic
    • On- and off-exchange plans
    • Arkansas Works plans
  • Service fee groups
  • Small group metallic plans
    • Transition of all small group metallic plans is scheduled for March 2018
  • Large group (50+) non-metallic plans
    • New non-metallic plans will always appear in ICM
    • Transition of existing non-metallic plans begins April 2018

Beginning in December 2017, all Short Term Blue policies will transition to ICM. Commissions will be paid in January 2018.

Beginning in January 2018, all remaining under-65 medical policies will transition to ICM. Commissions will be paid in February 2018. This includes:

Comp Blue PPO III


Blue Select

Comp Blue PPO

Comp Blue PPO II

Access Blue

Blue Choice

Blue Solution


HSA Blue PPO Plus

Blue Care PPO

Blue Care PPO Plus

Basic Blue



In January the transition of under-65 individual medical policies to ICM will happen at the same time. That means in February 2018 we'll start paying commissions on all of your under-65 medical policies in ICM.

Our end goal is to streamline commissions into one system and one commission statement. Adding under-65 individual medical to ICM means we're one step closer to improving our agent payment process.


Q. How do I know which commissions are paid from ICM versus MCS?

A. Commission statements from ICM and MCS are easily identifiable. Statements generated in ICM are colorful and include the Arkansas Blue Cross logo. Statements in MCS are black and white. ICM statements are divided by producer and further subdivided by new enrollments and renewals. Manual adjustments, if applicable, will be reported as a separate section as well.

Q. What are the similarities and differences between the two statements?

A. There are just a few differences between ICM and MCS statements.

Q. Will there be separate electronic funds transfer (EFT) deposits for commissions paid in ICM and MCS?

A. This is largely dependent on how the commissions in ICM and MCS are processed. If the payments are processed together, you should expect to see two-line item amounts — one for commissions paid in ICM and the other for commissions paid in MCS— on the email remittance that notifies you that a deposit was made. The ICM and MCS statements will always be separate on Blueprint for Agents.

Q. Will the statements be separate in Blueprint for Agents?

A. Yes, the statements will be separate in Blueprint for Agents. Individual under-65 medical commissions will appear behind the ICM link. Please refer to the example below that illustrates how statements will be separated by a separate link to each type of commission statement.

BpA Remittance Screen
Q. Will statements be available in both PDF and Excel format?

A. Yes, both MCS and ICM statements will be available in PDF and XLS.

Q. Are the policies I see on the ICM statements a comprehensive list of my policies?

A. No. The policies that appear on the commission statement are only those policies paid for that commission month. Please refer to enrollment listings on Blueprint for Agents for a list of your current policy and/or group enrollments.

Q. For individual business, what payment periods will be reflected in ICM?

A. With the exception of Medi-Pak Advantage and Part D, payment periods for individual policies in ICM will be paid one month in arrears.

Q. What about retroactivity? Will I have to look through MCS statements to find retroactivity on individual business?

A. In February 2018, ICM will start paying commissions on under-65 individual medical policies for January 2018 premium periods. ICM will not bring in commission history from commissions paid in MCS. Any retroactivity prior to January 2018 premium periods will be reflected on the MCS statement.